Literature DB >> 23937663

Influenza infection results in local expansion of memory CD8(+) T cells with antigen non-specific phenotype and function.

Gail D Sckisel1, Julia K Tietze, Anthony E Zamora, Hua-Hui Hsiao, Stephen O Priest, Danice E C Wilkins, Louis L Lanier, Bruce R Blazar, Nicole Baumgarth, William J Murphy.   

Abstract

Primary viral infections induce activation of CD8(+) T cells responsible for effective resistance. We sought to characterize the nature of the CD8(+) T cell expansion observed after primary viral infection with influenza. Infection of naive mice with different strains of influenza resulted in the rapid expansion of memory CD8(+) T cells exhibiting a unique bystander phenotype with significant up-regulation of natural killer group 2D (NKG2D), but not CD25, on the CD44(high) CD8(+) T cells, suggesting an antigen non-specific phenotype. We further confirmed the non-specificity of this phenotype on ovalbumin-specific (OT-I) CD8(+) T cells, which are not specific to influenza. These non-specific CD8(+) T cells also displayed increased lytic capabilities and were observed primarily in the lung. Thus, influenza infection was shown to induce a rapid, antigen non-specific memory T cell expansion which is restricted to the specific site of inflammation. In contrast, CD8(+) T cells of a similar phenotype could be observed in other organs following administration of systemic agonistic anti-CD40 and interleukin-2 immunotherapy, demonstrating that bystander expansion in multiple sites is possible depending on whether the nature of activation is either acute or systemic. Finally, intranasal blockade of NKG2D resulted in a significant increase in viral replication early during the course of infection, suggesting that NKG2D is a critical mediator of anti-influenza responses prior to the initiation of adaptive immunity. These results characterize further the local bystander expansion of tissue-resident, memory CD8(+) T cells which, due to their early induction, may play an important NKG2D-mediated, antigen non-specific role during the early stages of viral infection.
© 2013 British Society for Immunology.

Entities:  

Keywords:  NKG2D; antigen non-specific; bystander activation; memory CD8; tissue-resident

Mesh:

Substances:

Year:  2014        PMID: 23937663      PMCID: PMC3898557          DOI: 10.1111/cei.12186

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  68 in total

1.  Bystander activation of CD8+ T lymphocytes during experimental mycobacterial infection.

Authors:  Brad Gilbertson; Susie Germano; Pauline Steele; Steven Turner; Barbara Fazekas de St Groth; Christina Cheers
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

2.  Frequency, specificity, and sites of expansion of CD8+ T cells during primary pulmonary influenza virus infection.

Authors:  Christopher W Lawrence; Rebecca M Ream; Thomas J Braciale
Journal:  J Immunol       Date:  2005-05-01       Impact factor: 5.422

Review 3.  NKG2D in NK and T cell-mediated immunity.

Authors:  Kouetsu Ogasawara; Lewis L Lanier
Journal:  J Clin Immunol       Date:  2005-11       Impact factor: 8.317

4.  A virus-specific CD8+ T cell immunodominance hierarchy determined by antigen dose and precursor frequencies.

Authors:  Nicole L La Gruta; Katherine Kedzierska; Ken Pang; Richard Webby; Miles Davenport; Weisan Chen; Stephen J Turner; Peter C Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-17       Impact factor: 11.205

5.  The vast majority of CLA+ T cells are resident in normal skin.

Authors:  Rachael A Clark; Benjamin Chong; Nina Mirchandani; Nooshin K Brinster; Kei-Ichi Yamanaka; Rebecca K Dowgiert; Thomas S Kupper
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

6.  CD25+CD4+ regulatory T cells and memory T cells prevent lymphopenia-induced proliferation of naive T cells in transient states of lymphopenia.

Authors:  Christine Bourgeois; Brigitta Stockinger
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

7.  Functional differences between memory and naive CD8 T cells.

Authors:  B K Cho; C Wang; S Sugawa; H N Eisen; J Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

8.  Quantitating the magnitude of the lymphocytic choriomeningitis virus-specific CD8 T-cell response: it is even bigger than we thought.

Authors:  David Masopust; Kaja Murali-Krishna; Rafi Ahmed
Journal:  J Virol       Date:  2006-12-06       Impact factor: 5.103

9.  NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection.

Authors:  Monia Draghi; Achal Pashine; Bharati Sanjanwala; Ketevan Gendzekhadze; Claudia Cantoni; David Cosman; Alessandro Moretta; Nicholas M Valiante; Peter Parham
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

10.  HIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blasts.

Authors:  Jeffrey Ward; Matthew Bonaparte; Jennifer Sacks; Jacqueline Guterman; Manuela Fogli; Domenico Mavilio; Edward Barker
Journal:  Blood       Date:  2007-05-18       Impact factor: 22.113

View more
  22 in total

Review 1.  Bystander T Cells: A Balancing Act of Friends and Foes.

Authors:  Sarah K Whiteside; Jeremy P Snook; Matthew A Williams; Janis J Weis
Journal:  Trends Immunol       Date:  2018-11-06       Impact factor: 16.687

2.  Late administration of murine CTLA-4 blockade prolongs CD8-mediated anti-tumor effects following stimulatory cancer immunotherapy.

Authors:  Gail D Sckisel; Annie Mirsoian; Myriam N Bouchlaka; Julia K Tietze; Mingyi Chen; Bruce R Blazar; William J Murphy
Journal:  Cancer Immunol Immunother       Date:  2015-09-30       Impact factor: 6.968

3.  T-Cell Receptor Diversity and the Control of T-Cell Homeostasis Mark Ebola Virus Disease Survival in Humans.

Authors:  Emily Speranza; Paula Ruibal; Julia R Port; Feng Feng; Lia Burkhardt; Adam Grundhoff; Stephan Günther; Lisa Oestereich; Julian A Hiscox; John H Connor; César Muñoz-Fontela
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

4.  Aging influences the response of T cells to stimulation by the ellagitannin, oenothein B.

Authors:  Andrew G Ramstead; Igor A Schepetkin; Kimberly Todd; James Loeffelholz; James G Berardinelli; Mark T Quinn; Mark A Jutila
Journal:  Int Immunopharmacol       Date:  2015-04-15       Impact factor: 4.932

5.  Distinct activation thresholds of human conventional and innate-like memory T cells.

Authors:  Chloe K Slichter; Andrew McDavid; Hannah W Miller; Greg Finak; Brenda J Seymour; John P McNevin; Gabriela Diaz; Julie L Czartoski; M Juliana McElrath; Raphael Gottardo; Martin Prlic
Journal:  JCI Insight       Date:  2016-06-02

6.  Out-of-Sequence Signal 3 Paralyzes Primary CD4(+) T-Cell-Dependent Immunity.

Authors:  Gail D Sckisel; Myriam N Bouchlaka; Arta M Monjazeb; Marka Crittenden; Brendan D Curti; Danice E C Wilkins; Kory A Alderson; Can M Sungur; Erik Ames; Annie Mirsoian; Abhinav Reddy; Warren Alexander; Athena Soulika; Bruce R Blazar; Dan L Longo; Robert H Wiltrout; William J Murphy
Journal:  Immunity       Date:  2015-07-28       Impact factor: 31.745

Review 7.  The Ugly Duckling Turned to Swan: A Change in Perception of Bystander-Activated Memory CD8 T Cells.

Authors:  Nicholas J Maurice; Alexis K Taber; Martin Prlic
Journal:  J Immunol       Date:  2021-02-01       Impact factor: 5.422

8.  The IL-15-based superagonist ALT-803 promotes the antigen-independent conversion of memory CD8+ T cells into innate-like effector cells with antitumor activity.

Authors:  Hing C Wong; Emily K Jeng; Peter R Rhode
Journal:  Oncoimmunology       Date:  2013-10-09       Impact factor: 8.110

Review 9.  Tissue-Resident Memory T Cells in Antifungal Immunity.

Authors:  Salomé LeibundGut-Landmann
Journal:  Front Immunol       Date:  2021-05-25       Impact factor: 7.561

Review 10.  Significance of bystander T cell activation in microbial infection.

Authors:  Hoyoung Lee; Seongju Jeong; Eui-Cheol Shin
Journal:  Nat Immunol       Date:  2021-08-05       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.